Takeda Ventures

Portfolio Companies 2026 for Takeda Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Takeda Ventures accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $1.3B. The median disclosed raise is $70M, and the largest is VelosBio at $213M, ahead of Obsidian Therapeutics ($200M) and Naurex ($162M).

The names that recur most often on these portfolio cap tables are Takeda Ventures (13 companies), Atlas Venture (3 companies), Surveyor Capital (2 companies), Cormorant Asset Management (2 companies), Foresite Capital (2 companies), Janus Henderson Investors (2 companies). By latest disclosed round, the market skews Series C (4), Series A (4), Series B (3), Seed (1).

Best funded Takeda Ventures companies

  1. VelosBio — $213M (latest: Seed)
  2. Obsidian Therapeutics — $200M (latest: Series C)
  3. Naurex — $162M (latest: Series C)
  4. Palleon Pharmaceuticals — $147M (latest: Series B)
  5. Xilio Therapeutics — $95M (latest: Series C)
  6. StrideBio — $82M (latest: Series B)
  7. Ensoma — $70M (latest: Series A)
  8. Koneksa Health — $65M (latest: Series C)
  9. Egle Therapeutics — $60M (latest: Growth)
  10. Be Biopharma — $52M (latest: Series A)
  11. Catamaran Bio — $42M (latest: Series A)
  12. hC Bioscience — $40M (latest: Series A)
  13. Hookipa Pharma — $30M (latest: Series B)

Takeda Ventures — related firms and companies (55)

Takeda Ventures profile · All research reports